ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,462.00
0.25%
다우존스 지수
38,675.68
1.18%
Bitcoin
64,288.36
0.45%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Prime Medicine Inc (PRME)

  7. Prime Medicine Inc (PRME) 뉴스

PRME Prime Medicine Inc

5.59
0.00 (0.00%)
시간외 단일가
최종 업데이트: 20:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Prime Medicine Inc PRME 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 5.59 20:00:00
개장가 저가 고가 종가 전일 종가
5.59
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202421:00GLOBEPrime Medicine to Participate in the 27th Annual Milken..
29/04/202420:00GLOBEPrime Medicine Announces FDA Clearance of Investigational..
23/04/202421:00GLOBEPrime Medicine to Present Preclinical Data Demonstrating..
01/03/202422:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/03/202422:04EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/03/202422:01EDGAR2Form 8-K - Current report
01/03/202422:00GLOBEPrime Medicine Reports Full Year 2023 Financial Results and..
28/02/202422:00GLOBEPrime Medicine to Participate in Upcoming Investor..
24/02/202407:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/02/202407:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202411:31EDGAR2Form SC 13D - General statement of acquisition of beneficial..
21/02/202407:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/02/202406:01GLOBEPrime Medicine Announces Closing of Upsized Public Offering..
16/02/202420:23EDGAR2Form 8-K - Current report
16/02/202420:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/02/202413:50GLOBEPrime Medicine Announces Pricing of Upsized Public Offering
15/02/202411:57EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
15/02/202407:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/02/202406:12EDGAR2Form 8-K - Current report
15/02/202406:05GLOBEPrime Medicine Announces Proposed Public Offering of Common..
25/01/202422:00GLOBEPrime Medicine Receives Up to $15 Million from Cystic..
08/01/202422:01EDGAR2Form 8-K - Current report
06/01/202407:03EDGAR2Form 8-K - Current report
05/01/202422:15EDGAR2Form 8-K - Current report
05/01/202422:00GLOBEPrime Medicine Appoints Allan Reine, M.D., as Chief..
02/01/202422:00GLOBEPrime Medicine to Present at 42nd Annual J.P. Morgan..
14/11/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
08/11/202322:00GLOBEPrime Medicine to Present at Upcoming Investor Conferences
04/11/202306:23EDGAR2Form S-3 - Registration statement under Securities Act of..
04/11/202306:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/11/202305:06EDGAR2Form 8-K - Current report
04/11/202305:01GLOBEPrime Medicine Reports Third Quarter 2023 Financial Results..
27/10/202319:00GLOBEPrime Medicine Presents First-ever Prime Editing Data in..
24/10/202320:30GLOBEPrime Medicine Presents First In Vivo Proof-of-Concept Prime..
17/10/202321:00GLOBEPrime Medicine to Highlight Positive Preclinical..
19/09/202321:00GLOBEPrime Medicine to Present at Upcoming Investor Conferences
31/08/202321:00GLOBEPrime Medicine to Present at Upcoming Investor Conferences
08/08/202305:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202305:04EDGAR2Form 8-K - Current report
08/08/202305:01GLOBEPrime Medicine Reports Second Quarter 2023 Financial Results..
22/06/202321:00GLOBEPrime Medicine and Cimeio Therapeutics Announce Research..
31/05/202321:00GLOBEPrime Medicine to Present at Investor Conferences in June
18/05/202305:05GLOBEPrime Medicine to Present at Virtual Investor Conferences in..
17/05/202319:00GLOBEPrime Medicine to Present New Preclinical Data Highlighting..
11/05/202321:00GLOBEPrime Medicine Reports First Quarter 2023 Financial Results..

최근 히스토리

NASDAQ
PRME
Prime Medicine
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유